CAMBRIDGE, Mass.--(BUSINESS WIRE)--Iterative Scopes, a pioneer in the development of precision-based gastrointestinal disease technologies, announced today that it has entered into a collaboration ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Iterative Scopes, a pioneer in precision medicine technologies for gastroenterology, announced today that its artificial intelligence platforms will be featured in ...

The technology of Iterative Scopes technology is still in clinical testing, but Lilly sees enough promise to get an equity stake in the Cambridge, Massachusetts-based startup. The pharmaceutical giant ...

Iterative Scopes obtained $150 million in series B funding to develop its artificial intelligence-powered gastroenterology technology, the company said Jan. 19. The financing comes after the company ...

Healthcare costs attributed to cancer treatments were roughly $84.8 billion in 2014 in the United States. Colonoscopies are performed once a decade for individuals over the age of fifty to monitor and ...

Iterative Scopes is developing artificial intelligence software that can spot signs of inflammatory bowel disease and early indicators of colorectal cancer during standard colonoscopies and other ...

Iterative Scopes, a gastroenterology-focused software company, received FDA 510(k) clearance for its AI-assisted polyp detection device, Skout. Skout uses advanced computer vision technology to ...

Iterative Scopes Inc. picked up $30 million in series A financing to advance artificial intelligence (AI)-powered precision medicine for gastroenterology. The money will be used to further develop the ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Iterative Scopes, the MIT spinout developing AI-powered ...

CAMBRIDGE, Mass., March 17, 2021 /PRNewswire/ -- Iterative Scopes, a leading Artificial Intelligence in Gastroenterology provider, today announced the expansion of its world class Scientific Advisory ...